Viemed Healthcare, Inc.

NASDAQ:VMD

Medical - Devices

Healthcare
$8.78 +0.68%

+$0.07 today

Market cap
$332.70M
Beta
1.13
P/E (TTM)
27.4
EPS (TTM)
$0.39
52W Low $5.93High $10.68

Volume 0.26M

Average 0.26M

VMD Depreciation & Amortization

Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.

Viemed Healthcare, Inc.NASDAQ: VMD

Depreciation & Amortization · Q1 FY2026 · quarter ended Mar 2026

Depreciation & amortization grows in line with its trailing trend

Q1 FY2026 depreciation & amortization of $7.62M rose 15.2% year over year, in line with the +15.3% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 0.7% from the prior quarter. Over 3 fiscal years it compounded at +22.3% a year.

Context

  • Depreciation & amortization amounted to 10.6% of revenue in FY2025, down 0.7 pp from a year earlier.
  • Depreciation & amortization increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +15.2% toward the trailing-twelve-month pace of +15.3%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$7.62M+0.7% QoQ
Last fiscal yearDec 2025
$28.61M+12.8% YoY
LTMMar 2026
$29.62M+15.3% YoY
Depreciation & Amortization past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+15.2%——
1 year+12.8%——
3-year CAGR+22.3%——
5-year CAGR——
10-year CAGR——

Depreciation & Amortization history

USD · from the income statement

Latest · FY2025
28.61M USD
Year-over-year change
+12.8%
4-year CAGR
+26.1%

Depreciation & Amortization vs competitors

How VMD compares with its peers on the latest reported figures

  • VMD's LTM Mar 2026 depreciation & amortization of $29.62M is the highest of the 11 companies compared; the peer median is $2.21M.
  • Its year-over-year change of +15.3% is the 5th highest of 11, against a peer median of -0.7%.
  • Depreciation & amortization amounts to 10.3% of revenue for VMD, versus a peer median of 3.8%.
VMD Competitors Peer median
Depreciation & Amortization for VMD and competitors
Company Period LTM YoY 3-year CAGR% of revenue
VMDViemed Healthcare, Inc.LTM Mar 2026$29.62M +15.3%+22.3%10.3%
QTRXQuanterix CorporationLTM Mar 2026$21.08M +133.7%+51.8%14.5%
INGNInogen, Inc.LTM Mar 2026$20.37M -2.6%-4.2%5.8%
NNOXNano-X Imaging Ltd.LTM Dec 2025$11.7M -0.3%+0.5%89.8%
MASS908 Devices Inc.LTM Mar 2026$4.32M -7.0%+40.4%7.5%
OMOutset Medical, Inc.LTM Mar 2026$2.74M -56.6%-11.6%2.3%
SENSSenseonics Holdings, Inc.LTM Mar 2026$1.67M -1.0%+15.4%4.1%
SNWVSANUWAVE Health, Inc.LTM Mar 2026$1.59M +32.3%+10.5%3.6%
ELMDElectromed, Inc.LTM Mar 2026$1.2M +21.9%+23.1%1.7%
CVRXCVRx, Inc.LTM Mar 2026$777K +15.6%+22.4%1.3%
SGHTSight Sciences, Inc.LTM Mar 2026$441K -24.4%-27.0%0.6%
Peer median (excluding VMD) $2.21M-0.7%+12.9%3.8%

Competitors are the stored peer set for VMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue117.06M138.83M183.01M224.26M270.28M
Cost of Revenue43.65M54.15M70.23M91.05M114.82M
Gross Profit73.41M84.68M112.78M133.2M155.46M
Gross Margin62.7%61.0%61.6%59.4%57.5%
Research & Development2.11M2.7M2.78M3.07M3.02M
Selling, General & Admin60.04M73.36M93.73M112.48M130.5M
Operating Expenses61.83M76.43M98.45M115.3M134.75M
Depreciation & Amortization11.31M15.63M21.86M25.37M28.61M
EBITDA24.13M24.82M36.68M42.31M51.56M
EBITDA Margin20.6%17.9%20.0%18.9%19.1%
Operating Income11.58M8.25M14.33M17.9M20.71M
Operating Margin9.9%5.9%7.8%8.0%7.7%
Interest Income00000
Interest Expense318K197K424K776K1.18M
Other Income / Expenses923K738K61K(1.73M)1.06M
Income Before Tax12.5M8.99M14.39M16.17M21.77M
Pre-Tax Margin10.7%6.5%7.9%7.2%8.1%
Income Tax Expense3.38M2.77M4.15M4.76M6.39M
Net Income9.13M6.22M10.24M11.27M14.93M
Net Margin7.8%4.5%5.6%5.0%5.5%
EPS (Basic)0.230.150.270.290.38
EPS (Diluted)0.220.150.250.280.37
Weighted Avg Shares39.49M38.66M38.35M38.76M38.9M
Weighted Avg Shares (Diluted)40.68M39.81M40.38M40.81M40.82M

Viemed Healthcare, Inc.

NASDAQ:VMD

Intrinsic Alpha fair value

Locked

Current Price

$8.78

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.